Abbott Laboratories Aktie WKN: 850103 / ISIN: US0028241000

87,69EUR
-1,05EUR
-1,18%
102,73USD
-2,07USD
-1,98%
Diese Aktie kaufen
Werbung
mehr Daten anzeigen

Abbott Laboratories Aktie Analyse

27.08.20 Abbott Laboratories Sell Goldman Sachs Group Inc.
16.10.18 Abbott Laboratories overweight Barclays Capital
25.01.18 Abbott Laboratories Buy Stifel, Nicolaus & Co., Inc.
15.12.17 Abbott Laboratories Outperform BMO Capital Markets
19.10.17 Abbott Laboratories Buy Stifel, Nicolaus & Co., Inc.
19.10.17 Abbott Laboratories Outperform RBC Capital Markets
28.09.17 Abbott Laboratories overweight Barclays Capital
21.06.17 Abbott Laboratories Buy BTIG Research
Werbung
20.04.17 Abbott Laboratories overweight Barclays Capital
17.03.17 Abbott Laboratories Market Perform BMO Capital Markets
01.03.17 Abbott Laboratories Outperform RBC Capital Markets
26.01.17 Abbott Laboratories Outperform RBC Capital Markets
21.07.16 Abbott Laboratories overweight Barclays Capital
21.06.16 Abbott Laboratories Buy Edward Jones
11.04.16 Abbott Laboratories Outperform RBC Capital Markets
09.10.15 Abbott Laboratories Outperform RBC Capital Markets
07.10.15 Abbott Laboratories overweight Barclays Capital
23.07.15 Abbott Laboratories Equal weight Barclays Capital
23.07.15 Abbott Laboratories Buy Stifel, Nicolaus & Co., Inc.
23.07.15 Abbott Laboratories Outperform RBC Capital Markets
23.04.15 Abbott Laboratories Buy Stifel, Nicolaus & Co., Inc.
27.03.15 Abbott Laboratories Equal weight Barclays Capital
30.01.15 Abbott Laboratories Equal weight Barclays Capital
30.01.15 Abbott Laboratories Buy Stifel, Nicolaus & Co., Inc.
22.09.14 Abbott Laboratories Outperform RBC Capital Markets
07.01.13 Abbott Laboratories halten Deutsche Bank Securities
10.12.12 Abbott Laboratories buy UBS AG
29.11.12 Abbott Laboratories neutral Sarasin Research
15.11.12 Abbott Laboratories outperform RBC Capital Markets
07.11.12 Abbott Laboratories outperform RBC Capital Markets
07.11.12 Abbott Laboratories buy UBS AG
18.10.12 Abbott Laboratories neutral Sarasin Research
15.10.12 Abbott Laboratories buy UBS AG
15.10.12 Abbott Laboratories outperform RBC Capital Markets
05.10.12 Abbott Laboratories kaufen Fuchsbriefe
27.09.12 Abbott Laboratories outperform RBC Capital Markets
17.09.12 Abbott Laboratories buy UBS AG
06.08.12 Abbott Laboratories kaufen Die Actien-Börse
20.07.12 Abbott Laboratories outperform RBC Capital Markets
19.07.12 Abbott Laboratories buy UBS AG
06.06.12 Abbott Laboratories buy UBS AG
07.05.12 Abbott Laboratories outperform RBC Capital Markets
24.04.12 Abbott Laboratories outperform RBC Capital Markets
19.04.12 Abbott Laboratories outperform RBC Capital Markets
19.04.12 Abbott Laboratories neutral Sarasin Research
16.04.12 Abbott Laboratories outperform RBC Capital Markets
19.03.12 Abbott Laboratories outperform RBC Capital Markets
19.03.12 Abbott Laboratories buy UBS AG
01.03.12 Abbott Laboratories buy UBS AG
26.01.12 Abbott Laboratories outperform RBC Capital Markets
Seite: 1 | 2 | 3

Analysensuche

GO
Werbung

Kursziele Abbott Laboratories Aktie

-Abstand aktueller Kurs zum Ø Kursziel: -
Ø Kursziel: 94,00
Anzahl:
Buy: 0
Hold: 0
Sell: 0
75
80
85
90
95
100
105
110
Goldman Sachs Group Inc.
94,00 $
Abstand aktueller Kurs zum Ø Kursziel: -
Ø Kursziel: 94,00
alle Abbott Laboratories Kursziele

Aktuelle News zu

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln